Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Current Assets: 2011-2024

Historic Current Assets for Niagen Bioscience (NAGE) over the last 11 years, with Dec 2024 value amounting to $64.1 million.

  • Niagen Bioscience's Current Assets rose 79.57% to $93.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.6 million, marking a year-over-year increase of 79.57%. This contributed to the annual value of $64.1 million for FY2024, which is 29.41% up from last year.
  • According to the latest figures from FY2024, Niagen Bioscience's Current Assets is $64.1 million, which was up 29.41% from $49.5 million recorded in FY2023.
  • Over the past 5 years, Niagen Bioscience's Current Assets peaked at $64.1 million during FY2024, and registered a low of $32.2 million during FY2020.
  • Moreover, its 3-year median value for Current Assets was $49.5 million (2023), whereas its average is $53.4 million.
  • Its Current Assets has fluctuated over the past 5 years, first surged by 51.79% in 2021, then dropped by 4.78% in 2022.
  • Yearly analysis of 5 years shows Niagen Bioscience's Current Assets stood at $32.2 million in 2020, then spiked by 51.79% to $48.9 million in 2021, then dropped by 4.78% to $46.6 million in 2022, then increased by 6.37% to $49.5 million in 2023, then increased by 29.41% to $64.1 million in 2024.